Australia markets closed

Cardio Diagnostics Holdings, Inc. (CDIO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9052+0.1758 (+24.10%)
At close: 04:00PM EDT
0.8390 -0.07 (-7.31%)
Pre-market: 04:54AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 19.54M
Enterprise value 19.15M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)672.87
Price/book (mrq)6.61
Enterprise value/revenue 34.63k
Enterprise value/EBITDA -22.48

Trading information

Stock price history

Beta (5Y monthly) 5.25
52-week change 3-49.94%
S&P500 52-week change 326.27%
52-week high 33.5600
52-week low 30.1710
50-day moving average 31.1086
200-day moving average 31.2360

Share statistics

Avg vol (3-month) 3519.27k
Avg vol (10-day) 31.24M
Shares outstanding 521.59M
Implied shares outstanding 621.59M
Float 817.67M
% held by insiders 117.75%
% held by institutions 17.68%
Shares short (30 Apr 2024) 4336.48k
Short ratio (30 Apr 2024) 40.94
Short % of float (30 Apr 2024) 41.89%
Short % of shares outstanding (30 Apr 2024) 41.56%
Shares short (prior month 28 Mar 2024) 4444.63k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-29,039.51%

Management effectiveness

Return on assets (ttm)-84.51%
Return on equity (ttm)-230.77%

Income statement

Revenue (ttm)17.07k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)458.90%
Gross profit (ttm)N/A
EBITDA -7.13M
Net income avi to common (ttm)-8.38M
Diluted EPS (ttm)-0.6600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.28M
Total cash per share (mrq)0.06
Total debt (mrq)1.26M
Total debt/equity (mrq)42.63%
Current ratio (mrq)3.29
Book value per share (mrq)0.14

Cash flow statement

Operating cash flow (ttm)-5.67M
Levered free cash flow (ttm)-8.69M